MT10109L

· Medy-Tox

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for MT10109L, covering 2019-03-28 to 2024-08-09. Get the full timeline:

Most recent: Clinical Trial Update: MT10109L in the Long-term, Open-label Treatment of Glabellar Lines (GL) and Lateral Canthal Lines (LCL) [Phase 3]